The New Money
Posts
REalloys Lands U.S. Army Deal, The New SPAC For Humanoid Robots, And A Massive Raise For LSD

REalloys Lands U.S. Army Deal, The New SPAC For Humanoid Robots, And A Massive Raise For LSD

The markets and trends that matter, made simple. Discover what’s next.

June 27, 2026

U.S. Army Selects REalloys For Rare Earth Separation Facility

REalloys (NASDAQ: ALOY) has been conditionally selected by the United States Army to build a rare earth separation facility at the Tooele Army Depot located in Utah. REalloys will design, finance, build and operate the new rare earth separation plant as part of the new partnership with the United States Army to produce heavy rare earth oxides such as dysprosium and terbium for defense-critical magnet materials.

There’s A New SPAC Deal For Humanoid Robots

Humanoid robotics company Agility Robotics entered into a business combination with Churchill Capital Corp XI (NASDAQ: CCXI) to become a publicly traded company in a deal valuing the company at approximately $2.5 billion. Agility Robotics’ flagship humanoid robot Digit is capable of autonomously walking, lifting and carrying objects and navigating complex environments.

Definium Therapeutics Raises Mega Funding Round To Advance LSD Drug

Definium Therapeutics (NASDAQ: DFTX) successfully raised $805 million in a new equity financing round priced at $34.00 per share to advance their LSD based novel therapeutic DT120 ODT for major depressive disorder.

Conexeu Sciences: Architecting Bioregeneration

Conexeu Sciences (NASDAQ: CNXU) launched a preclinical development program for their 3D printed bioregenerative breast matrix which was recently successfully printed at the Wake Forest Institute for Regenerative Medicine.

The Sprint

Titan Mining (NYSE: TII) was conditionally selected by the United States Army for long term land leases at the Pine Bluff Arsenal in Arkansas and the Anniston Army Depot in Alabama to build out on-site purification plants for high purity graphite production.
FuelCell Energy (NASDAQ: FCEL) entered into a new deal with Fit Energy to deploy up to 380 megawatts of on-site power for data centres using their fuel cell technology.
NuCube Energy, developers of a solid-state fission microreactor, entered into a business combination with Launch Two Acquisition Corp (NASDAQ: LPBB) to become a publicly traded company.
REalloys (NASDAQ: ALOY) entered into a securities purchase agreement with institutional investors to raise $100 million in a new equity financing round at $14.25 per share.
Custom Health (TSX: CHLT) successfully completed a plan of arrangement and began trading on the Toronto Stock Exchange.
Elroy Air, an autonomous cargo drone company, entered into a business combination with Columbus Circle Capital Corp II (NASDAQ: CMII) to become a publicly traded company.
Cboe Global Markets (CBOE: CBOE) officially launched a new prediction markets platform known as Cboe Predicts.
CopperTech submitted a Form S-1 to the United States Securities and Exchange Commission to complete an IPO financing round and become a publicly traded company on the New York Stock Exchange.

The Markets This Week

+184.1% | Triller Group

+83.4% | Definium Therapeutics

+45.3% | Robo.ai

+34.2% | CEA Industries

+33.6% | AbCellera Biologics

+29.9% | AtaiBeckley

+25.3% | Viking Therapeutics

+21.4% | Usio Inc.

+18.3% | Compass Pathways

+16.3% | LanzaTech Global

Top Trends This Week

+16.8% | Psychedelic Stocks

+11.2% | Christian Angermayer

+8.9% | Weight Loss Drugs

+3.2% | Mike Novogratz

+2.1% | Ashton Kutcher

Looking to connect? Reach out and get in touch.

New here? Join our community of 100,000+ individuals interested in uncovering the world’s most exciting early stage companies.

Disclaimer: The New Money provides background information on early stage companies from publicly available sources. The New Money provides no advice on dealing in securities, is not a financial adviser and does not pretend to be so. This message is meant for information and educational purposes only. The information contained in this email is not to be considered factual or complete. Anybody interested in obtaining financial and other information on companies mentioned is advised to get it direct from the companies, or from their own investment adviser. The New Money does not intend for this information to be used to inform an investment decision. The New Money has been compensated by some of the companies mentioned in this email for awareness campaigns, which affects our ability to be unbiased. The Principals of The New Money may buy or sell shares of the mentioned companies without further notice. This is why we stress that you conduct extensive due diligence as well as seek the advice of your financial advisor or a registered broker-dealer before investing in any securities. The New Money and its principals and agents are not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Always do your own research and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment. Investing is inherently risky. While a potential for rewards exists, by investing, you are putting yourself at risk. You must be aware of the risks and be willing to accept them in order to invest in any type of security. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy or Sell securities. No representation is being made that any stock trade will or is likely to achieve profits. Comparisons made to other featured companies or past performance is not indicative of future results.